Putting public health back into the global cancer agenda

Annals of Oncology

Volumn 23, Issue 12, 2012, Pages 2995-2996

  Sullivan, R ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b Kings Health Partners Integrated Cancer Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

AFRICA; AGE DISTRIBUTION; CANCER CONTROL; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER PATIENT; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; CANCER THERAPY; COMMUNITY CARE; COST EFFECTIVENESS ANALYSIS; EDITORIAL; HEALTH CARE COST; HEALTH CARE FACILITY; HEALTH CARE MANPOWER; HEALTH CARE NEED; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH EDUCATION; INFORMATION DISSEMINATION; LIFE EXPECTANCY; LONG TERM CARE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL EDUCATION; MEDICAL RESEARCH; PATENT; POLITICAL PARTICIPATION; POLITICAL SYSTEM; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; PUBLIC HEALTH SERVICE; RISK ASSESSMENT; SOCIAL CLASS; SOCIAL STATUS; SOCIAL SUPPORT; TRADITIONAL MEDICINE; WORLD HEALTH ORGANIZATION;

DEVELOPING COUNTRIES; HEALTH SERVICES ACCESSIBILITY; HUMANS; NEOPLASMS;

EID: 84869785314     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mds522     Document Type: Editorial

References (13)

1. Abegunde DO, Mathers CD, Adam T et al. The burden and costs of chronic diseases in low-income and middle-income countries. Lancet 2007; 370(9603): 1929-1938.
2. Sullivan R, Purushotham AD. Avoiding the zero sum game in global cancer policy: beyond 2011 UN high level summit. Eur J Cancer 2011; 47(16): 2375-2380.
3. Love R, Ginsburg OM, Coleman CN. Public health oncology: a framework for progress in low-and middle-income countries. Ann Oncol 2012; 23(12): 3040-3045.
4. Chopra M, Lawn JE, Sanders D et al. Achieving the health millennium development goals for South Africa: challenges and priorities. Lancet 2009; 374 (9694): 1023-1031.
5. McMichael AJ, Beaglehole R. The changing global context of public health. Lancet 2000; 356(9228): 495-499.
6. Woodward D, Drager N, Beaglehole R et al. Globalization and health: a framework for analysis and action. Bull World Health Organ 2001; 79(9): 875-881.
7. Lingwood RJ, Boyle P, Milburn A et al. The challenge of cancer control in Africa. Nat Rev Cancer 2008; 8(5): 398-403.
8. Stuckler D, King L, Robinson H et al. WHO's budgetary allocations and burden of disease: a comparative analysis. Lancet 2008; 372(9649): 1563-1569.
9. Eckhouse S, Lewison G, Sullivan R. Trends in the global funding and activity of cancer research. Mol Oncol 2008; 2(1): 20-32.
10. Morgan G, Ward R, Barton M. The contribution of cytotoxic chemotherapy to 5-year survival in adult malignancies. Clin Oncol (R Coll Radiol) 2004; 16(8): 549-560.
11. Sullivan R, Behncke I, Purushotham A. Why do we love medicines so much? An evolutionary perspective on the human love of pills, potions and placebo. EMBO Rep 2010; 11(8): 572-578.
12. Smith RD, Mackellar L. Global public goods and the global health agenda: problems, priorities and potential. Global Health 2007; 3: 9.
13. Harmer A. Reshaping global health-a radical proposal for global health? globalhealthpolicy.net.